Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysisRuoyu Miao, Haitao Luo, Huandi Zhou et al.|Journal of Hepatology|2014Cited by 186
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinomaNan Zhang, Haitao Zhao, Shanshan Wang et al.|Biomarker Research|2024Cited by 82
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Bowen Chen et al.|Hepatology International|2023Cited by 60
Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expressionJianzhen Lin, Haitao Zhao, Junyu Long et al.|BMC Cancer|2018Cited by 57
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinomaXu Yang, Haitao Zhao, Baofeng Lian et al.|BMC Medicine|2024Cited by 43